SCHEMBL4132408

SCHEMBL4132408

COc1c(Cl)cc(OCC=C(Cl)Cl)cc1C(=O)C1CC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.37
GALK1 P51570 1/20 0.36
TYK2 P29597 1/20 0.34
MELK Q14680 2/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
GAA P10253 1/20 0.33
TAS1R3 Q7RTX0 2/20 0.32
TAS1R1 Q7RTX1 2/20 0.32
TAS1R2 Q8TE23 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
ALOX5 P09917 2/20 0.32
MAPT P10636 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
P2RX7 Q99572 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4D Q08499 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13696937 0.94 PDE4B (0.36) HTTGALK1ALDH1A1KDM4ETAS1R3
SCHEMBL13696939 0.84 ALDH1A1 (0.32) HTTGALK1ALDH1A1
SCHEMBL4505005 0.84 HTT (0.41) HTTGALK1ALDH1A1KDM4EGAA
SCHEMBL4621204 0.84 HTT (0.44) HTTGALK1ALDH1A1KDM4EGAA
SCHEMBL4518577 0.83 HTT (0.40) HTTGALK1ALDH1A1KDM4EGAA
SCHEMBL4512881 0.83 GALK1 (0.52) HTTGALK1ALDH1A1KDM4EGAA
SCHEMBL4125338 0.81 HTT (0.39) HTTGALK1ALDH1A1KDM4EGAA
SCHEMBL4509637 0.81 ALDH1A1 (0.49) HTTGALK1ALDH1A1KDM4EGAA
SCHEMBL13614127 0.80 HTT (0.42) HTTGALK1ALDH1A1KDM4EGAA
SCHEMBL13696938 0.79 MEN1 (0.31) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221596-A1 Substtituted aryl oximes BAYER CROPSCIENCE AG (DE) 2009-09-03 US disclosed
US-20090221596-A1 Substtituted aryl oximes BAYER CROPSCIENCE AG (DE) 2009-09-03 US disclosed
US-20090221596-A1 Substtituted aryl oximes BAYER CROPSCIENCE AG (DE) 2009-09-03 US disclosed
EP-1883622-A1 SUBSTITUTED ARYL OXIMES Bayer CropScience Aktiengesellschaft (DE) 2008-02-06 EP disclosed
WO-2007090434-A1 SUBSTITUTED ARYL OXIMES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2007-08-16 WO disclosed
WO-2007090434-A1 SUBSTITUTED ARYL OXIMES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221596-A1 Substtituted aryl oximes CYP1A1, PRDX1, CYP1A2 HTT 2381/4885GALK1 2294/4885TYK2 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.